Only July 30, 2026, China’s National Intellectual Property Administration (CNIPA) released the revised Measures for Administration of Priority Examination of Patents (Order No. 85) (专利优先审查管理办法（局令第85号）) effective September 1, 2026. Unlike the United States Patent & Trademark Office’s (USPTO) prioritized examination system, foreigners do not appear eligible to use China’s priority examination system.
Category: Patents
CNIPA Releases FAQ on Entering the National Phase in China from Patent Cooperation Treaty (PCT) Applications
On July 23, 2026, China’s National Intellectual Property Administration (CNIPA) released a Frequently Asked Questions (FAQ) regarding International Applications Entering into the China National Phase (国际申请进入中国国家阶段常见问题咨询). A translation follows. The original is available here (Chinese only).
WIPO Data Shows China’s Generative AI Patent Surge Outpacing the World
China has the largest volume of generative artificial intelligence (GenAI) patenting activity in the world, according to a report published July 14, 2026 by the World Intellectual Property Organization (WIPO). The findings, detailed in WIPO’s Technology SPARK Report, “Patent Trends Update in GenAI,” extend the analysis from WIPO’s 2024 Patent Landscape Report on Generative Artificial Intelligence through the end of 2025.
Chinese Supreme People’s Court Ruling Underscores the Role of Contemporaneous Technical Records in Determining Where an Invention Was Completed for Foreign-Filing Security Review Purposes
In a decision published July 13, 2026, the IP Tribunal of the Supreme People’s Court of China has issued a final ruling in (2022) 最高法知行终255号, upholding the validity of a diagnostic device patent owned by EDAN Diagnostics, Inc. against an invalidation challenge brought by Guangzhou Wan XX Biotechnology Co., Ltd. The decision offers guidance on how Chinese courts determine whether an invention’s “substantive content” was completed in China for purposes of the foreign-filing security review requirement under Article 20 of …